LUYE1039
`Luye Pharma Group Ltd., et al. v. Alkermes Pharma Ireland Ltd.
`IPR2016-01096
`
`

`

`~T----------------------------~~~===-~~--~~~~~~~--~~--~U~$~5
`1 mg
`CARBOXYMETHYLCELLULOSE
`500 g
`31.00
`~o-,o-CARBOXYGLUTAMICACID
`5 mg
`Sodium Salt
`1 kg
`..9
`C 4272 [64 153-47-5] C6H9N06
`FW 191.1
`10 mg
`A completely water-soluble
`2.5 kg
`3
`B§l
`polymer; not an ion exchanger.
`CM-Cellulose cation exchanger is listed in the
`DL·'Y·CARBOXYGLUTAMIC ACID
`Chromatography Section Page 1893
`C 3767 Free Acid
`[§] Crystalline
`USP Grade See Page 2158
`[56271-99-9] C6H9N06
`[9004-32-4}
`FW 191.1
`C 5678 Low viscosity
`Viscosity of 4% aqueous solution at 25'C: 50-
`14.50
`200 cps
`500 ,...g
`L"'Y·CARBOXYGLUTAMIC ACID
`24.15 C4888 Medium Viscosity
`1 mg
`C4147
`[53861-577] C,H,NO,
`FW 191.1
`76.60
`Viscosity of 2% aqueous solution at 25'C: 400-
`5 mg
`B§l
`800 cps
`1 mg
`31.35
`(S)-4-CARBOXY-3-HYDROXY-
`5 mg 125.40 C 5013 High Viscosity
`C 3586 L·PHENYLGLYCINE
`Viscosity of 1% aqueous solution at 25'C: 1500-
`f!!1
`(RS-3C4H-PGI
`3000 cps
`Metabotropic GluR2 agonist and GluR1 antagonist
`Ref.: 1. Birse, E.F., et al., Neuroscience, 52, 481
`CARBOXYMETHYL-CELLULOSE HYDRAZIDE
`(1993).
`See under: Affinity Chromatography Media Page 1925
`2. Orlando, L.R., et al., Neurosci. Lett., 202, 109
`(1995).
`1 g
`6.05
`S-CARBOXYMETHYL"l·CYSTEINE
`[85148-82·9} C,H,NOs FW 211.2
`C 7757 Crystalline
`5g
`10.70
`I •-•·c I
`R: 36/37/38 S: 26-36
`[638-23·3} C5H9NO,S FW 179.2
`25 g
`23.00
`100 g
`83.10
`N-(4-CARBOXY-3-HYDROXY-
`C 5511 PHENYL)MALEIMIDE
`25 mg 235.95
`~ Irreversible inhibitor of LDH isoenzyme M.
`Ref.: Carvajal, G., et al., National Cancer Institute
`Monograph No. 27, 111 (1967).
`[19232-43.0] CnH,NOs FW 233.2
`
`N·CARBOXYMETHYL-
`C 6206 6-(2,2-DICYANOVINYL)-
`1 •-•'C I
`1,2,3,4-TETRAHYDROQUINOLINE
`!CDCQI
`Minimum 98% (HPLC)
`Fluorescent molecular rotor
`5-CARBOXY-4-HYDROXY-2-THIOPYRIMIDINE
`Ref.: L lio, T., etal., J. Biochem., 113, 196 (1993).
`See: 5-Carboxy-2-thiouracil Page 239
`2. lwaki, T., et al., Biochemistry, 32, 7589 (19931.
`[47072·52~} C,,H"N,O, FW 267.3
`2-CARBOXYL·3·CARBOXYMETHYL·
`R: 36/37/38 S: 26-36
`4-ISOPROPENYLPYRROLIDINE
`See: Kainic Acid Page 650
`trls(CARBOXYMETHYL)ETHYLENEDIAMINE·
`AGAROSE
`CARBOXYLESTERASE
`See under: Affinity Chromatography Media Page 19 53
`See: Esterase Page 447
`Na,Na·bis(CARBOXYMETHYL)-
`50 mg
`37.50
`20.CARBOXY·LEUKOTRIENE B4
`C 3205 L-LYSINE
`250 mg 125.00
`I 2-= I
`C 6046 Minimum 90% (HPLC)
`(N-[5-Amino-1-carboxypentyl]-
`~ Approx. 1 mg per ml in ethanol
`iminodiacetic acid)
`Trlfluoroacetate Salt
`/80434·82-81 c,.H,.o, FW 366.5
`•
`Approx. 95% (TLC)
`R: 11-36/37/38 S: 16-26-36
`Ref.: Hochuli, E., et al., J. Chrom., 411, 177 (1987).
`7-CARBOXYMETHOXY-4-METHYL-
`[ 160369-83-5] C10H,8N206 • C2F302H FW 376.3
`C 8783 COUMARIN
`~ {64700.15-8] C12H1005 FW 234.2
`CARBOXYMETHYL SEPHADEX
`See: lon Exchangers and Gel Filtration Media
`R: 36/37/38 S: 26-36
`Page 1892
`N,N-bls(2-(bis(CARBOXYMETHYL)AMINO]ETHYL)·
`N-CARBOXYMETHYL"l·PHENYLALANYL-L·LEUCINE
`GLYCINE
`See: Bioactive Peptides Page I 164
`See Diethylenetriaminepentaacetic Acid Page 385
`1-(CARBOXYMETHYL)PYRIDINIUM
`2·((2·bis(CARBOXYMETHYL)AMIN0-5-METHYL-
`C 6513 CHLORIDE HYDRAZIDE
`PHENOXY]METHYL)-6-METHOXY-
`I 2-o·c I
`(Girard's Reagent PI
`8-bis(CARBOXYMETHYL)AMINOQUINOLINE
`Crystalline
`See: Quin 2 Page 965
`[1126-58-5] C,H,.CIN,O FW 187.6
`2·((2·bis(CARBOXYMETHYL)AMIN0-5-METHYL-
`(CARBOXYMETHYL)TRIMETHYL·
`PHENOXY]METHYL)·6-METHOXY-8-bis-
`C 1757 AMMONIUM CHLORIDE
`(CARBOXYMETHYL)AMINOQUINOLINE-tetrakls-
`1!!1
`HYDRAZIDE
`(ACETOXYMETHYL) ESTER
`(Girard's Reagent T)
`See: Quin 2-AM Page 965
`Crystalline
`{123-4~} C5H14N30CI FW 167.6
`3,3'-bls(N,N-di(CARBOXYMETHYL]AMINOMETHYL)-
`THYMOLPHTHALEIN
`6·CARBOXYMETHYLURACIL
`See: Thymolphthalein Complexone Page I 065
`See.· Uracil-4-acetic Acid Page 1 I 14
`CARBOXYMETHYLAMYLOSE
`6-CARBOXY-5·NITR0·2,4-DIOXYPYRIMIDINE
`C 4947 Sodium Salt
`See. 5-Nitroorotic Acid Page 799
`i!il
`Contains up to 4% ethanol
`I 12768-3 1-9}
`3-CARBOXY-4-NITROPHENYL DISULFIDE
`See: 5,5'-Dithiobis(2-nitrobenzoic acid) Page 4 23
`R: 36/37/38 S: 26-36
`237
`To place an order call800-325-3010 • Technical Service 800-325-5832
`
`15.75
`1 mg
`52.50
`5 mg
`25 mg 207.90
`
`250 mg 18.40
`
`25 ,...g 137.20
`Shipped in dry ice
`
`1 g
`
`39.10
`
`14.00
`1 g
`52.55
`5 g
`25 g 204.90
`
`I
`
`55
`
`
`
`31
`49
`
`25 g 14.60
`
`100 g 26.20
`
`us s I ~'U'M~fii I
`88.85
`
`1 mg
`
`CARBOXYETHYL THIOETHYL
`C 7788 2·ACETAMIDO·
`4·0·(2-ACETAMID0·2·DEOXY ·[3·o·GLUCO-
`@£)
`PYRANOSYL·6·0·(a·L·FUCOPYRANOSYL])·
`2-DEOXY·fl·o-GLUCOPYRANOSIDE·BSA
`CONJUGATE
`([fl-o-GicNAc-[1->4]-[a-L-F uc-[1->6ll-fl-o-GicNAc-
`1->0-CETE],-BSAI
`Approx. 10-30 moles trisaccharide per mole BSA
`Ref.: Montreuil, J., Adv. Carbohydr. Chem. Biochern
`37, 157 (1980).
`.,
`CARBOXYETHYLTHIOETHYL
`81.55
`1 mg
`C 7913 2-ACETAMID0-2-DEOXY·
`5 mg 271.05
`~ 4-0-fl·o-GALACTOPYRANOSYL·
`fl·o-GLUCOPYRANOSIDE-BSA CONJUGATE
`([fl-o-Gal-l 1->41-fl-o-GicNAc-1->0-CETEl,-BSA)
`Approx. 15-25 moles disaccharide per mole BSA
`Ref.: Lis, H., et al., Phytochemistry, 24, 2803
`(1985).
`1 mg
`CARBOXYETHYLTHIOETHYL
`C 7538 4-0-a-o-GALACTOPYRANOSYL· 5 mg
`~ fl·o-GALACTOPYRANOSIDE-BSA
`CONJUGATE
`([u-o-Gal-!1->41-fl-o-Gai-1 ->0-CETEJ,-BSAI
`15-30 moles disaccharide per mole BSA
`Ref.: Leffler, H. and Svanborg-Eden, C., FEMS
`Microbiol. Lett., 8, 127 (1980).
`CARBOXYETHYL THIOETHYL
`1 mg 135.35
`C 0539 4-0-(4-0-(6-0-a·o-GLUCO-
`~ PYRANOSYL-a-o-GLUCOPYRANOSYL]-
`" "o-GLUCOPYRANOSYL)·fl·o-GLUCO·
`PYRANOSIDE-BSA CONJUGATE
`([a-o-Gic-[1->6]-a-o-Gic-[1->4]-a-o-Gic-[1->4]-
`fl-o-Gic-1->0-CETE],-BSA)
`Approx. 10-20 moles tetrasaccharide per mole BSA.
`5-CARBOXYFLUORESCEIN
`50mg
`32.40
`C 0537 99% (HPLC)
`I 2..-c I
`[76823.03-5] C21H120 7 FW 376.3
`6-CARBOXYFLUORESCEIN
`C 0662 Approx. 97% (HPLC)
`[3301-79·9} C,.H"O' FW 376.3
`IE:£J
`5[6)-CARBOXYFLUORESCEIN
`38.20 C 7153 Mixed isomers
`63.65 I •-a'C I
`Approx. 99% (HPLC)
`A probe for liposome-cell interactions.
`Ref.: Ralston, E., et al., Biochim. Biophys. Acta, 649,
`133 (1981).
`C,,H,,O, FW 376.3
`5-CARBOXYFLUORESCEIN
`C 4916 DIACETATE
`(5-CFDAI
`@£l
`Approx. 95% (HPLC)
`Ref.: Bruning, J.W., et al., J. lmmunol. Methods., 73,
`33 (1980).
`[79955·27-4] C, H,.O, FW 460.4
`R: 45-46-23/24/25-36/37/38 S: 45-26-36/37/39-
`22
`6-CARBOXYFLUORESCEIN Dl-
`17.30
`57.50 C 5041 ACETATE
`191.55 @£l
`(6-CFDAI
`Approx. 95% (HPLC)
`Ref.: Goodall, H., et al., Nature, 295, 524 (1982).
`[3348.03~] C, H,.o, FW 460.4
`R: 23/24/25-36/37/38 S: 45-26-36/37/39
`31.20
`5(6)-CARBOXYFLUORESCEIN
`25 mg
`43.30
`86.55
`122.60 C 8166 DIACETATE
`100 mg
`Mixed isomers
`250 mg 190.45
`@£l
`Approx. 95% (HPLC)
`C, H,.O, FW 460.4
`How to use catalog - page 2.
`
`289,
`
`67.95
`
`289,
`
`NL-
`
`42.80
`97.20
`L 71.30
`
`~29
`
`66.15
`164.60
`
`>lasmic
`
`982).
`
`46.65
`
`37.30
`
`1ge 5.
`
`163.90
`545.80
`
`50 mg
`
`32.40
`
`32.40
`50 mg
`250 mg 128.30
`
`25 mg
`100 mg
`
`27.40
`84.65
`
`25 mg
`100 mg
`
`26.80
`81.00
`
`LUYE1039
`Luye Pharma Group Ltd., et al. v. Alkermes Pharma Ireland Ltd.
`IPR2016-01096
`
`

`

`PRODUCT
`NUMBER
`
`CALCIUM GLUCONATE, USP
`C 8231 Anhydrous
`[299-28-51 c,H, cao ..
`(!!)
`FW 430.4
`CALCIUM LACTATE, USP
`C 8356 Pentahydrate
`[5743-47-51 C6H10Ca06 • 5H20
`I 2-a·c I
`FW 308.3
`CALCIUM PANTOTHENATE, USP
`I 137-1)8-61 c,.H,CaN,O,,
`C 8731
`FW 476.5
`I z-a'C I
`CALCIUM PHOSPHATE, Dibasic,
`C 8606 USP
`[7757-93·91 CaHP04 FW 136.1
`(!!)
`R: 36/37/38 S: 26-36
`CAPTOPRIL, USP
`C 8856 ([2S]-1-[3-Mercapto-2-methyl-
`propionylh-prolinel
`[jjj]
`[62571·86-21 C9H15NO,S
`FW 217.3
`R: 62-43 S: 36-22
`CARBAMAZEPINE, USP
`C 8981
`[298-46-41 C15H12N20 FW 236.3
`R: 22-42/43 S: 36/37/39-22
`I 2- a·c I
`CARBENICILLIN, USP
`C 9231 Disodium Salt
`[48Q0-94-61 C17H16N206SNa,
`I 2-a-c I
`FW 422.4
`R: 42/43 S: 36
`CARBOXYMETHYLCELLULOSE,
`C 9481 USP
`Sodium Salt
`(!!)
`Medium Viscosity
`{9004-32-41
`CASTOR OIL, USP
`c 9606
`[8001 -79-41
`R: 36/38 S: 26-36
`(!!)
`CETYLPYRIDINIUM CHLORIDE,
`C0732 USP
`(1-Hexadecylpyridinium chloride)
`(!!)
`Monohydrate
`[6004-24-61 C21H38CIN • H20
`S: 26-36
`CHARCOAL, ACTIVATED, USP
`C 7606 R: 20-36/37/38 S: 22-26-36
`[jjj]
`
`100 g
`500 g
`1 kg
`
`250 g
`500 g
`1 kg
`
`25 g
`100 g
`1 kg
`100 g
`500 g
`2.5 kg
`
`32.95
`54.90
`98.90
`
`42.45
`137.75
`1179.40
`10.75
`35.75
`135.45
`
`1 g
`5g
`25 g
`
`28.80
`95.30
`316.85
`
`5g
`25 g
`
`36.55
`114.90
`
`1 g
`5g
`10 g
`
`93.80
`321.90
`608.90
`
`500 g
`1 kg
`2.5 kg
`
`50.20
`68.00
`150.95
`
`39.20
`70.65
`
`26.40
`187.70
`595.25
`
`500 ml
`1 liter
`
`100 g
`1 kg
`5 kg
`
`FW 358.0
`
`125 g
`500 g
`2.5 kg
`25 g
`100 g
`500 g
`
`26.65
`75.75
`171.40
`49.05
`158.40
`615.40
`
`2158
`
`----
`
`10 g
`100 g
`250 g
`
`24.
`110:
`235 .•
`
`100 g
`1 kg
`5 kg
`
`49 ..
`276.
`11 16 5
`
`1 mg
`10mg
`50 mg
`
`22.4
`11!.3(
`440 ...
`
`S: 53-45-
`
`100 mg
`1 g
`5g
`
`5 g
`33.0C
`10 g
`58.80
`50 g 23!.40
`
`(Continuation oO
`CITRIC ACID_,_USP.
`. . . . . . . . . . . ········
`c 1732 Monohydrate
`100 g
`15.
`[5949-29-11 C,H.o , • H,O
`[jjj]
`1 kg
`111
`FW 210.1
`25 kg
`200\_
`R: 41-37/38 S: 26-36
`CUPRIC SULFATE, USP
`38
`250 g
`64:
`c 2857 Pentahydrate
`500 g
`[7758-99-81 Cuso. • 5H,O
`[jjj]
`2.5 kg
`254 ..
`FW 249.7
`R: 60-63-22-41-37/38-43 S: 45-26-36/37;39_22
`--.....:::...
`CYANOCOBALAMIN, USP
`500 mg
`38
`C3607 (Vitamin B,l
`5 g
`223
`[68·19·91 FW 1355.4
`12-I'C I
`25g 1040 <
`S:36
`CYSTEINE_, _H)tdroc_hloride~ ~SP
`C3482 Anhydrous
`[52-8911 C,H,NO,S • HCI
`[jjj]
`FW 157.6
`R: 36/37/38 _ S: 26-36
`C3357 Monohydrate
`[7048-1)4-61 C3H,N02S • HCI
`(!!)
`• H,O FW 175.6
`R: 36/ 37/38 S: 26-36
`DAUNORUBICIN, Hydrochloride,
`D8809 USP
`(Daunomycin)
`I 2-a-c I
`[23541-50-61 C27H29N010
`• HCI FW 564.0
`R: 45-46-61-22-36/37/38-42/43
`36!37 /39-22
`DEXAMETHASONE,USP
`35.51
`D 9184
`(9«-Fiuoro-16a-methyl-
`155.1
`l >-<"< I
`prednisolone; 9a-Fiuoro-
`553.8(
`16«·methyl-1 1j3,17a,21-
`trihydroxy-1 ,4-pregnadiene-3, 20-dione; Prednisolone
`F)
`[50-02-21 C22H29F05 FW 392.5
`R: 63-36/37/38-43 S: 26-36-22
`DEXTROMETHORPHAN, USP
`D 9684 Hydrobromide: Monohydrate
`[67D0-34·1 1 C,0H, NO • HBr
`(!!)
`• H20 FW 370.3
`R: 22 S: 36
`DEXTROSE,USP
`(Glucose)
`D 9434 Anhydrous
`23.45
`250 g
`sao g
`39.00
`[50-99-71 c6H, o. FW 180.2
`(!!)
`..... 2.5_ kg . !10.00
`100 g
`I 1.10
`I kg
`61.80
`25 kg 1000.00
`10 g
`15.65
`100g 110.15
`
`5g
`25 g
`
`28.55
`90.40
`
`49.90
`5g
`25 g 161.80
`
`ocUSATE,USP
`0 Sulfobutanedioic acid bis[2-ethyl
`Jl685 ~exyl ester]; Dioctyl sulfosuccma
`sodium Salt
`1517./1-71 C20H,NaO,S FW 4
`R: 22-36/37/38-41 S: 26-36
`------oErA TE, USP
`E (EDTA; Ethylenediaminetetra-
`1 1)399 acetic actdl
`.
`Oisodium Salt: Dthydrate
`[6381 -92-61 C10H"N,OsNa,
`• zH,O FW 372.2
`R: 22-36/37/38 S: 26-36
`~
`774 [ i/4./)7·8 1 C"H.,NO"
`E0
`FW 733.9
`R: 42/43 S: 36
`----EsfRAoiOL, USP
`(17j3·Estradiol;_ 1 ,3,5[10]-Estra-
`24
`EI0
`triene-3,1713-dtol;
`"
`3,17~-Dihydroxy-1,3,5[10]·
`estratrienel
`15o-z8-21 C,,H,.O, FW 272.1
`R: 60-61 S: 53-45-36/37/39-
`-------ESTRIOL, USP
`1149 (!,3,5[10]-Estratriene-
`3,16a,l7[3·tnol;
`.
`E
`"
`!6a-Hydroxyestradtol;
`316a 17(l-Trihydroxy-1,3,5[H
`rso-zf-1 1 c,,H,.o, FW 288.
`R: 60-61 S: 53-45-36/37/39
`ESTRONE, USP
`(!,3,5[1 0]-Estratrien-3-ol-17-ot
`0 274
`3-Hydroxy-1 ,3,5(10]-estratnen
`11
`one)
`[53- 1671 C,sH,O, FW 270.
`R: 60-61 S: 53-45-36/37/35
`ETHYLENEDIAMINE, USP
`E 1649 [ 1 07·15·3 I C,H,N, FW 60.1
`:EJ
`R: 10-21/22-34-43 S: 9-26-
`•
`36/37/39-45
`FERROUS FUMARATE, USP
`F7923 [141-1) 1-51 C,H,FeO. FW II
`i!1
`R: 22 S: 36
`FERROUS SULFATE, USP
`F 8048 Heptahydrate
`Iill
`[7782-63-01 FeSO, • 7H,O
`FW 278.0
`R: 22-36/37/ 38 S: 26-36
`FLUOROURACIL, USP
`F8423
`[51-21·81 C,H,FN,O, FW 1
`R: 46-60-61-22-36/37/38 ~
`:!11
`26-27-36/37/39
`FLUPHENAZINE, USP
`F 8548 Hydrochloride
`ii:
`{146-56-51 C, H,.F,N,OS •
`FW 510.4
`R: 20/21/22 S: 36
`FOLIC ACID, USP
`F 8798 (Pteroylglutamic acid; Vitam it
`C, H,.N,O• FW 441.4
`!!:
`FORMALDEHYDE SOLUTION,
`F8923 USP
`.!il
`(Formalin)
`[5o-D0-01 CH10 FW 30.02
`R: 23/24/25-34-40-43 S: :
`FRUCTOSE, USP
`~9048 [57-48-71 C6H"O' FW 181
`!!J
`
`To place an 01
`
`CHLORAMPHENICOL, USP
`C 0857
`(Chloromycetin; o-[- ]-threo-
`2-Dichloroacetamido-1-[p-nitro-
`[jjj]
`phenyl]-1, 3-propanedioll
`D 9559 Monohydrate
`[56-75-71 C11H12CI2N205 FW 323.1
`[5996·10-11 c.H,O• • H,O
`(!!)
`R: 45-46-63-42/43 S: 45-36/37/39
`FW 198.2
`18.55
`5 g
`CHLORPROMAZINE, USP
`DIATRIZOIC ACID, USP
`47.35
`25 g
`C 0982 Hydrochloride
`100 g 126.45 D 9809
`[50978-11-51 C" H91,N,O,
`[69-1)9-1)1 C,,H,CIN,S • HCI
`(!!)
`FW 613.9
`(!!)
`•
`FW 355.3
`R: 26-25-36/37/38 S: 45-26-36/37/39-22
`DIBU(;AINE_, _USP_
`250mg
`CHOLECALCIFEROL, USP
`17.65 D 0185 Free Base
`C 1357
`(Activated 7-dehydrocholesterol;
`1 g
`29.05
`[85·79·01 C,.H, N,O, FW 343.5
`(!!)
`I ,...c 1
`Vitamin 031
`25 g
`371.25
`R: 41-37 S: 26-36
`[67-97-01 C,H .... O FW 384.6
`•
`D 0310 Hydrochloride
`R: 60-64-63-25 S: 45-36/37/39
`[61-12-1 1 C20H29N302 • HCI
`(!!)
`CITRIC ACID, USP
`FW 379.9
`................
`13.00 _ __ :_::R:~4:._:1 _::·3~7_::::S:~2:::6·_::3:-_6 ________ -:
`100 g
`C 1857 Anhydrous
`[77-9291 c.H,O, FW 192.1
`DIMETHYL SULFOXIDE, USP
`92.85
`500 ml
`37.4S
`1 kg
`(!!)
`R: 41-37/38 S: 26-36
`_25 kg _ 1750.~0 D 1435
`[67-68-51 C2H6SO FW 78.14
`!liter 62.5C
`· ···· ···········
`4 liter !59.1~
`(Continued)
`R: 36/37/38 S: 26-36-23
`(!!)
`+ Shipping information · page 5.
`How to use catalog - page 2.
`
`LUYE1039
`Luye Pharma Group Ltd., et al. v. Alkermes Pharma Ireland Ltd.
`IPR2016-01096
`
`